Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils

Journal of Infection and Chemotherapy

Volumn 9, Issue 4, 2003, Pages 297-303

  Sasahara, Takeshi ^a   Satoh, Yoshinori ^a   Sekiguchi, Tomoko ^a   Suzuki, Kaoruko ^a   Irinoda, Kazuhiko ^a   Takayama, Yoko ^a   Sakamoto, Ayako ^b   Kitasato, Hidero ^a   Okamoto, Ryoichi ^a   Inoue, Matsuhisa ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Apoptosis; Imipenem; Postantibiotic leukocyte enhancement; Pseudomonas aeruginosa; Sub MIC

Indexed keywords

CATALASE; CEFTAZIDIME; IMIPENEM; OXYGEN RADICAL;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; INCUBATION TIME; INTERMETHOD COMPARISON; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM CELL; PHAGOCYTOSIS; POSTANTIBIOTIC EFFECT; POSTANTIBIOTIC LEUKOCYTE ENHANCEMENT EFFECT; PROTEIN MODIFICATION; PSEUDOMONAS AERUGINOSA; STRAIN IDENTIFICATION;

EID: 9144262987     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0264-4     Document Type: Article

References (33)

1. Adinolfi LE, Bonventre RF. Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MIC of imipenem. Antimicrob Agents Chemother 1988;32:1012-8.
2. Mandell LA, Afnan M. Mechanism of interaction among subinhibitory concentrations of antibiotics, human polymorphonuclear neutrophilis, and gram-negative bacilli. Antimicrob Agents Chemother 1991;35:1291-7.
3. Yourtee EL, Root RK. Antibiotic-neutrophil interactions in microbial killing. In: Gallin JI, Fauci AS, editors. Advances in host defence mechanisms. vol. 1. New York: Raven: 1991. p. 187-209.
4. Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V. editor. Antibiotics in laboratory medicine. 3rd Ed. Baltimore: Williams and Wilkins; 1991. p. 403-31.
5. Bustamante CI, Drusano GL, Tatem BY, Standiford HC. Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob Agents Chemother 1984;26:678-82.
6. Herrera-Insua I, Perez P, Martinez P, Gomez-Lus ML, Prieto J. Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes. J Antimicrob Chemother 1997;39:223-8.
7. Novelli A, Fallani S, Cassetta MI, Conti S, Mazzei T. Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains. Antimicrob Agents Chemother 2000;44:3174-6.
8. Nadler HL, Pitkin DH, Sheikh W. The postantibiotic effect of meropenem and imipenem on selected bacteria. J Antimicrob Chemother 1989;24:(Suppl A)225-31.
9. Delogu G, Iona E, Amati F, Marandola M, Costantini D, Baumgartner IM, et al. Killing of Pseudomonas aeruginosa isolated from patients with critical post-operative complications. Effect of various antibiotics. Ann Ital Chir 1997;68:219-24.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th Ed. Approved standard Mt-A4. Wayne, PA: NCCLS; 2000.
11. Masihi KN, Azuma I, Brehmer W, Lange W. Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs. Infect Immun 1983;40:16-21.
12. Beers RF, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1951;195:133-40.
13. Nakamura T, Yanagisawa T, Yamaguchi M. Studies of the subunits of myosin from muscle layer of Ascaris Lumbricoides suum. Biochim Biophys Acta 1975;412:22940-40.
14. Baran J, Guzik K, Hryniewicz W, Erns M, Flad DH, Pryjma J. Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria. Infect Immun 1996;64:4242-8.
15. Hirai Y, Nakahata H, Aoki R, Tsujino M, Kumasaka Y, Takebe K. Synergetic bactericidal effect of cefuzonam with human polymorphnuclear leukocytes. Chemotherapy (Tokyo) 1991;39:452-8.
16. Iida K, Nakamuta S, Hirata S, Koike M, Resumption of cell division in piperacillin-induced filaments of Escherichia coli. J Antimicrob Chemother 1982;9:451-9.
17. Kanafani H, Martin SE. Catalase and superoxide dismutase activities in virulent and nonvirulent Staphylococcus aureus isolates. J Clin Microbiol 1985;21:607-10.
18. Miyazaki S, Tsuji A, Tetsuo I, Kitaya S, Kaneko Y, Goto S. Relationship between superoxide dismutase and catalase activities of gram-negative bacilli and the pathogenicity to mouse polymorphonuclear leukocytes. Jpn J Bacteriol 1986;41:535-9.
19. Isturiz R, Metcalf JA, Root RK. Enhanced killing of penicillin-treated gram-positive cocci by human granulocytes: role of bacterial autolysins, catalase, and granulocyte oxidative pathways. Yale J Biol Med 1985;58:133-43.
20. De Assis MC, Da Costa AO, Barja-Fidalogo TC, Plotkowski MC. Human endothelial cells are activated by interferon-gamma plus tumor necrosis factor-alpha to kill intracellular Pseudomonas aeruginosa. Immunology 2000;101:271-8.
21. Yu H, Schurr MJ, Deretic V. Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J Bacteriol 1995;77:3259-68.
22. Dacheux D, Attree I, Schneider C, Toussaint B. Cell death of human polymorphonuclear neutrophilis induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system. Infect Immun 1999;67:6164-7.
23. Fukuda W, Takemura S, Yanagida K, Okamoto M, Kasamatsu Y, Onodera H, et al. Enhancement of bactericidal effect of serum complement by imipenem. Chemotherapy (Tokyo) 1990;38:676-8.
24. Yahr TL, Goranson J, Frank DW. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol Microbiol 1996;22:991-1003.
25. Evans K, Passador R, Srikumar E, Tsang E, Nezezon J, Poole K. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol 1998;180:5443-7.
26. Hirakata Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med 2002;196:109-18.
27. Dacheux D, Toussaint B, Richard M, Brochier G, Croize J, Attree I. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Infect Immun 2000;68:2916-24.
28. Decheux D, Attree I, Schneider C, Toussaint B. Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system. Infect Immun 1999;67:6164-7.
29. Finlay BB, Gumbiner B, Falkow S. Penetration of Salmonella through a polarized Madine-Darby canine kidney epithelial cell monolayer. J Cell Biol 1988;107:221-30.
30. Jendrossek V, Grassmé H, Mueller I, Lang F, Gulbins E. Pseudomonas aeruginosa-induced apoptosis involves mitochondria and stress-activated protein kinases. Infect Immun 2001;69:2675-83.
31. Sumita Y, Eguchi Y, Fukasawa S, Matsumura H, Sunagawa M. The effect of 1β-methyl and imidoyl substituents on the antipseudomonal activity of carbapenems. J Antibiotics 1993;46:1629-32.
32. Matsuda K, Inoue M. Evaluation of antibiotics by the method of initial bactericidal activity. Jpn J Antibiot 2000;53:667-71.
33. Gudmundsson S, Vogelman B, Craig WA. The in-vivo post-antibiotic effect of imipenem and other new antimicrobials. J Antimicrob Chemother 1986;18:(Suppl E)67-73.